Company research / AMRX

Amneal Pharmaceuticals, Inc. (AMRX)

CIK 0001723128 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Amneal Pharmaceuticals, Inc. reported revenue of $3.02B. Revenue grew 8.0% from the prior annual period.

Key ratios (year ended 2025-12-31)

36.9%
Gross margin
13.1%
Operating margin
2.4%
Net margin
8.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-09-02

Headquarters locality: Hayward / Bridgewater Township · View on map

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.